Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
02/1999
02/11/1999WO1999006440A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
02/11/1999WO1999006062A1 Cyclic peptide antifungal agents
02/11/1999WO1998050057A3 Agent for enhancing the heart force
02/11/1999DE19729591A1 Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen Agents for the treatment and / or prophylaxis of microcirculation disorders
02/11/1999CA2301184A1 Cyclic peptide antifungal agents
02/11/1999CA2298101A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
02/10/1999EP0896003A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
02/10/1999EP0896001A1 Method for preparing oxytocin antagoniste derivatives, intermediates for the preparation of oxytocin antagonist derivatives and method for preparing the intermediates
02/09/1999US5869603 Amino acid sequences of synthetic peptides binding to neutralizing antibodies against recombinant interferon-beta; for detection and inhibition of antibodies in patients
02/09/1999US5869602 Glucagon having lipophilic substituent on epsilon-amino group of lysine in position 30
02/09/1999US5869452 Treatment of obesity
02/09/1999US5869451 Activate the thrombopoietin receptor.
02/09/1999US5869449 Improved antibacterial activity against some clinical isolates of staphylococci somewhat resistant to teicoplanin.
02/09/1999US5869447 Cyclohexapeptides and their mixtures, a process for preparing them, and their use
02/09/1999US5869445 Methods for eliciting or enhancing reactivity to HER-2/neu protein
02/09/1999US5869337 Regulated transcription of targeted genes and other biological events
02/09/1999US5869265 Screening modulators by contacting recombinant cells which express cotransporter with substance, determining increase or decrease in activity; anticholesterol agents; antidiabetic agents; liver disease; crohn's disease
02/09/1999CA2226091C Cyclosporin-containing soft capsule preparations
02/04/1999WO1999005527A2 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
02/04/1999WO1999005313A2 Method for typing of minor histocompatibility antigen ha-1
02/04/1999WO1999005174A1 The ha-1 antigen
02/04/1999WO1999005173A1 The ha-1 antigen
02/04/1999WO1999005172A2 Pharmaceuticals for modulating hormone responsiveness
02/04/1999WO1999005169A1 Epitopes of shigella like toxin and their use as vaccine and in diagnosis
02/04/1999CA2298930A1 Pharmaceuticals for modulating hormone responsiveness
02/04/1999CA2298887A1 The ha-1 antigen
02/04/1999CA2297491A1 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
02/04/1999CA2266456A1 Method for typing of minor histocompatibility antigen ha-1
02/03/1999EP0894093A2 Soluble tachykinin antagonists, the preparation and use thereof
02/03/1999EP0894092A1 A cyclic hepta-peptide derivative from colonial ascidians, lissoclinum sp.
02/03/1999EP0894002A1 Novel peptides which inhibit complement activation
02/03/1999CN1207044A Cyclosporin-containing soft capsule preparations
02/03/1999CN1207043A Inhibitors of cyclophilin rotamase activity
02/02/1999US5866694 Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates
02/02/1999US5866692 Process for producing humanized chimera antibody
02/02/1999US5866684 Peptidyl inhibitors of viral proteases
02/02/1999US5866682 Short peptides about 14-17 residues in length, which are naturally available in minute amounts in the venom of the cone snails.
02/02/1999US5866681 Oligopeptides
02/02/1999US5866679 Peptides
02/02/1999US5866544 Peptide-chelator conjugates
02/02/1999US5866541 Genetic engineering
02/02/1999US5866540 Cyclic adhesion inhibitors
02/02/1999US5866384 Cell ablation using trans-splicing ribozymes
02/02/1999US5866319 Dna probe capacble of hybridizing with genome
02/02/1999US5866129 Method of producing an antibody with a peptide corresponding to membrane-bound IgA
02/02/1999US5866097 Technetium-99m labeled peptides for imaging
01/1999
01/28/1999WO1999004018A1 Chimeric contraceptive vaccines
01/28/1999WO1999003879A1 Dolastatin 15 derivatives
01/28/1999WO1998046632A3 Inhibitors for urokinase receptor
01/27/1999EP0558671B1 Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
01/27/1999EP0542770B1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
01/27/1999CN1206423A Peptide derivatives of Dolastatin 15 and their use
01/26/1999US5864026 Systematic evolution of ligands by exponential enrichment: tissue selex
01/26/1999US5864012 Oligopeptides as antitumor agents
01/26/1999US5864010 Enzyme inhibitor; antiinflammatory agent
01/26/1999US5863901 Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders
01/26/1999US5863900 Lhrh antagonists
01/26/1999US5863899 Analgesics and antiinflammatory agent; a morphine or derivative is attached to brandykinin antagonist peptide by maleimido or amino acid analog linker
01/26/1999US5863889 ICAM-1/LFA-1 short-chain peptides and method of using same
01/26/1999US5863774 Cell ablation using trans-splicing ribozymes
01/26/1999US5863763 Insect neuropeptides
01/26/1999US5863549 Methods for the sustained release of biologically active compounds
01/21/1999WO1999002690A1 Systemin
01/21/1999WO1999002565A2 Agent for the treatment and/or prophylaxis of microcirculation disorders
01/21/1999WO1999002551A1 Integrin binding peptide and use thereof
01/21/1999WO1999002550A1 Ctl epitopes from ebv
01/21/1999WO1999002548A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium
01/21/1999WO1999002185A1 Methods and compositions for impairing multiplication of hiv-1
01/21/1999WO1999002175A1 Conjugates useful in the treatment of prostate cancer
01/21/1999DE19730786A1 New human neutrophil-lymphocyte peptide and its fragments
01/21/1999CA2295860A1 Conjugates useful in the treatment of prostate cancer
01/21/1999CA2295688A1 Agent for the treatment and/or prophylaxis of microcirculation disorders
01/21/1999CA2294732A1 Ctl epitopes from ebv
01/20/1999EP0891982A2 HIV peptides
01/20/1999EP0891377A1 Inhibitor and stimulator of stem cell proliferation and uses thereof
01/20/1999EP0891376A1 Antifungal peptides from scleroderma texense
01/19/1999US5861483 Inhibitor of stem cell proliferation and uses thereof
01/19/1999US5861478 Lytic peptides
01/19/1999US5861381 Pharmaceutical composition for the treatment of a malignant tumor
01/19/1999US5861318 Mixing with biotin conjugated acceptor peptide, radioactive nucleotide sugar, and avidin coated beads; high speed; measuring radioactivity
01/19/1999US5861262 Method of the specific immunoassay of human plasma glutathione peroxidase, kit for its implementation, oligopeptides and antibodies specific for the method
01/19/1999US5861243 Amino acid sequences
01/19/1999CA2067748C Dye transfer inhibition
01/14/1999WO1999001472A1 Cyclic azapeptides with angiogenic effect
01/14/1999WO1999001471A1 Nik proteins, nucleic acids and methods
01/14/1999CA2297181A1 Cyclic azapeptides
01/13/1999EP0890840A2 Assaying for collagen degradation in vivo
01/13/1999EP0889902A1 Antibiotic peptides from bovine milk
01/13/1999EP0889901A1 Process and intermediates for the synthesis of lhrh antagonists
01/13/1999CN1041634C Oxytocin antagonist and compound and use thereof
01/12/1999US5859189 Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes
01/12/1999US5859188 Method for discovering novel anthelmintic compounds
01/12/1999US5859187 Inhibit the ul42 stimulation of the herpes virus dna polymerase activity
01/12/1999US5859185 HCMV-specific peptides, agents therefor and the use thereof
01/12/1999US5859184 Alpha-helix mimetics and methods relating thereto
01/12/1999US5858979 Anticoagulant peptides
01/12/1999US5858972 Cyclic peptide
01/12/1999US5858971 Cyclic peptide and method of making same by culturing a strain of actinomyces S. nobilis
01/12/1999US5858964 Immunosuppressant
01/12/1999US5858689 Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof